BLOZFBLOZFOTC

Overview Intelligence Charts News Fundamentals

Latest News

prnewswire.com

Journal of Analytical Toxicology Publishes Peer‑Reviewed Validation Study Demonstrating Accuracy of Omega Laboratories' Test Method for Detecting Marijuana in Breath Samples Using Cannabix Technologies' Breath Collection Unit

MOGADORE, Ohio and VANCOUVER, BC, March 3, 2026 /PRNewswire/ -- Omega Laboratories, Inc. and Cannabix Technologies Inc. (CSE: BLO) (OTCID: BLOZF) proudly announce the peer‑reviewed publication of a groundbreaking study published by Oxford University Press in the prestigious Journal of Analytical Toxicology titled: "Simultaneous Analysis of Δ9‑THC, Δ8‑THC, CBD, and CBN in Breath Aerosols Collected Using Cannabix Technologies Breath Collection Unit." This marks a major milestone in the advancement of marijuana breath testing technology globally.

globenewswire.com

Cannabix Technologies Closes Non-Brokered Private Placement

NOT FOR DISTRIBUTION TO UNITED STATES NEWS WIRE SERVICES ORFOR DISSEMINATION IN THE UNITED STATES VANCOUVER, British Columbia, Feb. 24, 2026 (GLOBE NEWSWIRE) -- Cannabix Technologies Inc. (CSE: BLO) (the “Company” or “Cannabix”) announces it has closed its previously announced non-brokered private placement financing (the "Offering") with the issuance of 1,400,000 units of the Company (the “Units”) at an issue price of CDN$0.50 per Unit for aggregate gross proceeds of CDN$700,000. Each Unit consists of one common share in the capital of the Company (a “Share”) and one non-transferable common share purchase warrant (a “Warrant”).

defenseworld.net

Cannabix Technologies (OTCMKTS:BLOZF) Stock Price Down 3.6% – Time to Sell?

Shares of Cannabix Technologies Inc. (OTCMKTS:BLOZF - Get Free Report) dropped 3.6% during trading on Wednesday. The stock traded as low as $0.3914 and last traded at $0.4035. Approximately 134,463 shares changed hands during mid-day trading, an increase of 29% from the average daily volume of 104,623 shares. The stock had previously closed at

globenewswire.com

Cannabix Technologies announces Non-Brokered LIFE Private Placement

NOT FOR DISTRIBUTION TO UNITED STATES NEWS WIRE SERVICES OR FOR DISSEMINATION IN THE UNITED STATES

globenewswire.com

Cannabix Marijuana Breath Test Featured on the Cover of AlcoPro's 2026 Product Catalog

VANCOUVER, British Columbia, Jan. 22, 2026 (GLOBE NEWSWIRE) -- Cannabix Technologies Inc. (CSE: BLO) (OTCID: BLOZF) (Frankfurt: 8CT) (the “Company” or “Cannabix”) a developer of marijuana and alcohol breath-testing devices, is pleased to announce that its Marijuana Breath Test (“MBT”) will be featured on the cover of the 2026 AlcoPro Inc. product catalogue (see Figure 1). AlcoPro Inc. (“AlcoPro”), based in Knoxville, TN, is a leading U.S. supplier of professional drug and alcohol testing instruments, kits, and supplies, serving customers since 1982. The 2026 AlcoPro product catalogue will be distributed to more than 85,000 businesses across the United States and internationally including law enforcement and the corrections segment.

defenseworld.net

Cannabix Technologies (OTCMKTS:BLOZF) Trading 0.1% Higher – Should You Buy?

Cannabix Technologies Inc. (OTCMKTS:BLOZF - Get Free Report) shares rose 0.1% during trading on Friday. The stock traded as high as $0.46 and last traded at $0.4240. Approximately 93,879 shares changed hands during mid-day trading, a decline of 32% from the average daily volume of 137,831 shares. The stock had previously closed at $0.4237.

defenseworld.net

Short Interest in Cannabix Technologies Inc. (OTCMKTS:BLOZF) Increases By 105.8%

Cannabix Technologies Inc. (OTCMKTS:BLOZF - Get Free Report) was the target of a significant growth in short interest during the month of December. As of December 15th, there was short interest totaling 52,257 shares, a growth of 105.8% from the November 30th total of 25,390 shares. Currently, 0.0% of the shares of the stock are

globenewswire.com

Cannabix Technologies Launches New Marijuana Breath Test Product Videos as U.S. Cannabis Reclassification Underscores the Urgent Need for Innovative Public Safety Solutions

VANCOUVER, British Columbia, Dec. 19, 2025 (GLOBE NEWSWIRE) -- Cannabix Technologies Inc. (CSE: BLO) (OTCID: BLOZF) (Frankfurt: 8CT) (the “Company or Cannabix”) developer of marijuana and alcohol breath devices is pleased to announce that it has launched new product videos showcasing the Company's Marijuana Breath Test (MBT) solution (Figures 1 and 2). These videos highlight the MBT's advanced features and benefits, including its ability to detect recent cannabis use through non-invasive breath sampling—helping enhance workplace safety and providing law enforcement with innovative tools for roadside screening. The new videos can be viewed at www.cannabixtechnologies.com (see additional links below). The U.S. Administration's executive order to fast-track the reclassification of marijuana to Schedule III under the Controlled Substances Act amplifies the spotlight on cannabis use and its growing liberalization across the country. This policy shift underscores the critical need for Cannabix's Marijuana Breath Test (MBT) solution—providing an easy-to-use method to detect recent cannabis use and support public safety in workplaces and on highways.

defenseworld.net

Cannabix Technologies (OTCMKTS:BLOZF) Trading 1.2% Higher – Here’s Why

Cannabix Technologies Inc. (OTCMKTS:BLOZF - Get Free Report)'s stock price rose 1.2% on Wednesday. The company traded as high as $0.3799 and last traded at $0.3694. Approximately 56,938 shares traded hands during trading, a decline of 38% from the average daily volume of 91,668 shares. The stock had previously closed at $0.3650. Cannabix Technologies

globenewswire.com

Cannabix Technologies Strengthens Presence in Maritime Market with Repeat BreathLogix Alcohol Screening Device Order

VANCOUVER, British Columbia, Dec. 02, 2025 (GLOBE NEWSWIRE) -- Cannabix Technologies Inc. (CSE: BLO) (OTCID: BLOZF) (Frankfurt: 8CT) (the “Company or Cannabix”) developer of marijuana and alcohol breath devices is pleased to announce that it has entered into a second sales agreement for its BreathLogix unmanned alcohol screening technology with an existing European maritime shipping customer. Under this agreement, the Company will deliver an additional BreathLogix unit to enhance operational safety among crew members through pre-access breath alcohol testing. The BreathLogix system will be integrated with the cloud-based BreathLogix Connect platform, powered by Amazon Web Services, enabling real-time alerts, centralized data management, and seamless reporting. Additionally, the device will feature facial recognition technology for rapid and secure crew member identification.

globenewswire.com

Cannabix Technologies announces Non-Brokered LIFE Private Placement

NOT FOR DISTRIBUTION TO UNITED STATES NEWS WIRE SERVICES OR FOR DISSEMINATION IN THE UNITED STATES

globenewswire.com

Cannabix Technologies Granted Patent from USPTO for Contactless Breath Analysis

VANCOUVER, British Columbia, Oct. 27, 2025 (GLOBE NEWSWIRE) -- Cannabix Technologies Inc. (CSE: BLO) (OTC PINK: BLOZF) (Frankfurt: 8CT) (the “Company or Cannabix”) is pleased to report that the United States Patent and Trademark Office (USPTO) has granted patent No. 18/1729,658 entitled, “Contact-Free Breath Analysis Device and Method” to the Company.

globenewswire.com

Cannabix Technologies Delivers BreathLogix Alcohol Screening Device to Oilfield Transportation Services Company

VANCOUVER, British Columbia, Oct. 16, 2025 (GLOBE NEWSWIRE) -- Cannabix Technologies Inc. (CSE: BLO) (OTC PINK: BLOZF) (Frankfurt: 8CT) (the “Company or Cannabix”) developer of marijuana and alcohol breath devices is pleased to report the delivery of its BreathLogix technology to an oil and gas transportation services company located in northern Alberta, Canada. The BreathLogix system is designed for rapid, unmanned testing and is tailored for industries where safety is critical, including mining, oil and gas, industrial operations, trucking, warehousing, and maritime sectors. This adoption underscores Cannabix's commitment to providing innovative solutions that help reduce risk and promote a culture of safety.

globenewswire.com

Cannabix Technologies to Participate at U.S. National Institute of Standards and Technology (NIST) Cannabis Breathalyzer Workshop

VANCOUVER, British Columbia, Sept. 18, 2025 (GLOBE NEWSWIRE) -- Cannabix Technologies Inc. (CSE: BLO) (OTC PINK: BLOZF) (Frankfurt: 8CT) (the “Company or Cannabix”) developer of marijuana and alcohol breath testing devices reports that it will be attending the inaugural “Building a Path Forward for Meaningful Cannabis Breathalyzer Realization” workshop hosted by the United States National Institute of Standards and Technology (“NIST”).

globenewswire.com

Bill Corl of Omega Laboratories Joins Cannabix Technologies Board of Directors

VANCOUVER, British Columbia, Aug. 07, 2025 (GLOBE NEWSWIRE) -- Cannabix Technologies Inc. (CSE: BLO) (OTC PINK: BLOZF) (Frankfurt: 8CT) (the “Company or Cannabix”) is pleased to announce William (Bill) R. Corl has joined the board of directors of the Company. Mr. Corl is the Chief Executive Officer for Omega Laboratories, Inc., (“Omega”) one of the leading advanced specimen drug testing laboratories in the world. Omega and Cannabix have been working together since May 2024 under a strategic partnership and development agreement to advance commercialization of the Company's Marijuana Breath Test (MBT) technology.

globenewswire.com

Cannabix Technologies Receives Notice of Allowance from CIPO for Contactless Breath Analysis Patent Application

VANCOUVER, British Columbia, July 29, 2025 (GLOBE NEWSWIRE) -- Cannabix Technologies Inc. (CSE: BLO) (OTC PINK: BLOZF) (Frankfurt: 8CT) (the “Company or Cannabix”) is pleased to report that the Canadian Intellectual Property Office (CIPO) has issued a notice of allowance for patent application No. 3243445 entitled, “Contact-Free Breath Analysis Device and Method” to the Company. Recently the U.S. Patent and Trademark Office issued a notice of allowance for the same patent application filed in the United States. A notice of allowance indicates that the patent application has been approved by an examiner and that the Company can move forward with obtaining the patent granted upon payment of certain fees fee within a specified timeframe.

globenewswire.com

Cannabix Technologies Annual General and Special Meeting Results

VANCOUVER, British Columbia, July 24, 2025 (GLOBE NEWSWIRE) -- Cannabix Technologies Inc. (CSE: BLO) (OTC PINK: BLOZF) (the “Company”) announces the results of its annual general and special meeting of common shareholders held on July 24, 2025 in Vancouver. Resolutions passed at the meeting included the appointment of SHIM and Associates LLP as auditors for the ensuing year, and the election of five directors: Dr. Raj Attariwala, Dr. Phillip Olla, Ravinder Mlait, Bryan Loree, and William Corl.

globenewswire.com

Cannabix Technologies Commences First Production of BreathLogix Alcohol Screening Devices

VANCOUVER, British Columbia, July 15, 2025 (GLOBE NEWSWIRE) -- Cannabix Technologies Inc. (CSE: BLO) (OTC PINK: BLOZF) (Frankfurt: 8CT) (the “Company or Cannabix”) developer of marijuana and alcohol breath devices is pleased to report that it has directed Price Electronics to begin manufacturing BreathLogix alcohol screening device components for an initial commercial production run.

globenewswire.com

Cannabix Technologies Receives Notice of Allowance from USPTO for Contactless Breath Analysis

VANCOUVER, British Columbia, June 17, 2025 (GLOBE NEWSWIRE) -- Cannabix Technologies Inc. (CSE: BLO) (OTC PINK: BLOZF) (Frankfurt: 8CT) (the “Company or Cannabix”) is pleased to report that the United States Patent and Trademark Office (USPTO) has issued a notice of allowance for patent application No. 18/1729,658 entitled, “Contact-Free Breath Analysis Device and Method” to the Company.

globenewswire.com

Cannabix Technologies Enters Contract Manufacturing Agreement with Price Industries for BreathLogix Devices

Cannabix has developed an autonomous alcohol breathalyzer screening device for employers and a range of industries and safety settings Cannabix has developed an autonomous alcohol breathalyzer screening device for employers and a range of industries and safety settings

Loading news...

Explore More

S&P 500 Screener

Filter and sort all 500 stocks

Market Movers

Today's biggest gainers and losers

Market Heatmap

Visual sector performance